12:00 AM
 | 
Sep 14, 1998
 |  BC Week In Review  |  Company News  |  Deals

Anergen, Sunol deal

The companies extended their 1997 agreement to explore uses of Sunol's recombinant expression technology to produce recombinant human major histocompatibility complex (MHC)...

Read the full 87 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >